Teewinot Life Sciences

About:

Teewinot Life Sciences Corporation is a biopharmaceutical company

Website: https://tlscorp.com/

Twitter/X: teewinot

Top Investors: Tuatara Capital

Description:

Teewinot Life Sciences is a global biopharmaceutical company focused on the biosynthetic production of pure pharmaceutical grade cannabinoids. Teewinot has developed patent protected processes for production of pure cannabinoids by means of biocatalysis and synthetic biology. Teewinot has also developed patent protected cannabinoid formulation technology all with the goal of improving human therapies. Headquartered in Tampa, Florida, Teewinot manufactures and licenses technology to make cost-effective and pharmaceutically pure cannabinoids. We are an industry leader in support of advancing medical research and product development. Teewinot’s global technology and intellectual property represent a breakthrough in the creation and delivery of cannabinoid-based medicines.

Total Funding Amount:

$19.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tampa, Florida, United States

Founded Date:

2015-01-01

Contact Email:

contact(AT)tlscorp.com

Founders:

Christopher Brink, Jeffrey M. Korentur

Number of Employees:

11-50

Last Funding Date:

2017-05-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai